Salbutamol Sulfate Inhalation, 0.09 MG


Indications and Reactions:

Role Indications Reactions
Primary
Asthma 64.6%
Chronic Obstructive Pulmonary Disease 10.3%
Asthma Exercise Induced 3.4%
Dyspnoea 3.4%
Wheezing 2.9%
Bronchitis 2.3%
Emphysema 1.7%
Asthmatic Crisis 1.1%
Blood Pressure 1.1%
Pneumonia 1.1%
Product Used For Unknown Indication 1.1%
Respiratory Disorder 1.1%
Respiratory Tract Infection 1.1%
Upper Respiratory Tract Infection 1.1%
Arthritis 0.6%
Asthma Prophylaxis 0.6%
Back Injury 0.6%
Bronchial Hyperreactivity 0.6%
Bronchospasm 0.6%
Croup Infectious 0.6%
Drug Ineffective 57.9%
Dyspnoea 6.2%
Drug Effect Decreased 5.9%
Throat Irritation 5.5%
Wheezing 2.6%
Haemoptysis 2.2%
Urticaria 1.8%
Asthma 1.5%
Dysphonia 1.5%
Oxygen Saturation Decreased 1.5%
Pneumonia 1.5%
Product Quality Issue 1.5%
Rash 1.5%
Respiratory Tract Irritation 1.5%
Therapeutic Response Decreased 1.5%
Therapeutic Response Delayed 1.5%
Vomiting 1.5%
Cough 1.1%
Dysgeusia 1.1%
Insomnia 1.1%
Secondary
Asthma 39.1%
Chronic Obstructive Pulmonary Disease 21.7%
Asthmatic Crisis 8.7%
Bronchitis 8.7%
Asthma Prophylaxis 4.3%
Bronchospasm 4.3%
Emphysema 4.3%
Respiratory Tract Infection 4.3%
Upper Respiratory Tract Infection 4.3%
Drug Ineffective 20.0%
Dyspnoea 20.0%
Drug Effect Decreased 10.0%
Insomnia 10.0%
Nightmare 10.0%
Rash 10.0%
Therapeutic Response Decreased 10.0%
Wheezing 10.0%

Drug Data